Since 1996 TriLink has offered cutting edge services to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. TriLink specializes in the manufacture of modified nucleic acid products including custom oligonucleotides, modified nucleoside triphosphates, CleanAmp™ PCR Products, RNA transcripts, phosphoramidites and other small molecules. TriLink’s founders have been on the forefront of the advancements in oligonucleotide synthesis. Their scientists and technicians have decades of collective experience in synthesizing modified nucleosides, nucleotides and oligonucleotides for research, diagnostics and pre-clinical therapeutic applications. Learn more at trilinkbiotech.com.